339 related articles for article (PubMed ID: 34199283)
1. Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review.
Munteanu AC; Uivarosi V
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34199283
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium complexes as antimicrobial agents.
Li F; Collins JG; Keene FR
Chem Soc Rev; 2015 Apr; 44(8):2529-42. PubMed ID: 25724019
[TBL] [Abstract][Full Text] [Related]
3. Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections.
D'Amato A; Mariconda A; Iacopetta D; Ceramella J; Catalano A; Sinicropi MS; Longo P
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139855
[TBL] [Abstract][Full Text] [Related]
4. Cationic Ru
Golbaghi G; Groleau MC; López de Los Santos Y; Doucet N; Déziel E; Castonguay A
Chembiochem; 2020 Nov; 21(21):3112-3119. PubMed ID: 32578299
[TBL] [Abstract][Full Text] [Related]
5. Coumarin-modified ruthenium complexes by disrupting bacterial membrane to combat Gram-positive bacterial infection.
Huang HY; Wang P; Deng W; Dou LX; Liao XW; Wang JT; Duan XM; Yu RJ; Xiong YS
Dalton Trans; 2023 Jul; 52(28):9757-9771. PubMed ID: 37395360
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity.
Riccardi C; Musumeci D; Trifuoggi M; Irace C; Paduano L; Montesarchio D
Pharmaceuticals (Basel); 2019 Sep; 12(4):. PubMed ID: 31561546
[TBL] [Abstract][Full Text] [Related]
7. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
Pal M; Nandi U; Mukherjee D
Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of ruthenium polypyridyl complexes against Staphylococcus aureus and biofilms.
Bu S; Jiang G; Jiang G; Liu J; Lin X; Shen J; Xiong Y; Duan X; Wang J; Liao X
J Biol Inorg Chem; 2020 Aug; 25(5):747-757. PubMed ID: 32564223
[TBL] [Abstract][Full Text] [Related]
9.
Komarnicka UK; Niorettini A; Kozieł S; Pucelik B; Barzowska A; Wojtala D; Ziółkowska A; Lesiów M; Kyzioł A; Caramori S; Porchia M; Bieńko A
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215281
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of ruthenium complexes functionalized with benzothiophene and their antibacterial activity against Staphylococcus aureus.
Liao X; Liu L; Tan Y; Jiang G; Fang H; Xiong Y; Duan X; Jiang G; Wang J
Dalton Trans; 2021 Apr; 50(16):5607-5616. PubMed ID: 33908929
[TBL] [Abstract][Full Text] [Related]
11. Identification of ruthenium (II) complexes with furan-substituted ligands as possible antibacterial agents against Staphylococcus aureus.
Liao X; Wang J; Jiang G; Lingyu M; Jiang G; Wang J; Huang B
Chem Biol Drug Des; 2021 Nov; 98(5):885-893. PubMed ID: 34453495
[TBL] [Abstract][Full Text] [Related]
12. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
13. Metal complexes as DNA intercalators.
Liu HK; Sadler PJ
Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
[TBL] [Abstract][Full Text] [Related]
14. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
15. Polymeric ruthenium precursor as a photoactivated antimicrobial agent.
Ghosh S; Amariei G; Mosquera MEG; Rosal R
J Hazard Mater; 2021 Jan; 402():123788. PubMed ID: 33254797
[TBL] [Abstract][Full Text] [Related]
16. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in ruthenium anticancer drugs.
Levina A; Mitra A; Lay PA
Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
[TBL] [Abstract][Full Text] [Related]
18. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
19. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.
Zeng L; Gupta P; Chen Y; Wang E; Ji L; Chao H; Chen ZS
Chem Soc Rev; 2017 Oct; 46(19):5771-5804. PubMed ID: 28654103
[TBL] [Abstract][Full Text] [Related]
20. Ru(ii), Ir(iii), Re(i) and Rh(iii) based complexes as next generation anticancer metallopharmaceuticals.
Das U; Kar B; Pete S; Paira P
Dalton Trans; 2021 Aug; 50(32):11259-11290. PubMed ID: 34342316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
